| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 98 | 2021 | 4420 | 4.640 |
Why?
|
| Chromosome Mapping | 114 | 2016 | 4740 | 3.510 |
Why?
|
| Genome | 66 | 2023 | 1808 | 3.090 |
Why?
|
| Human Genome Project | 20 | 2021 | 193 | 2.820 |
Why?
|
| Genomics | 54 | 2021 | 5720 | 2.200 |
Why?
|
| Genetic Linkage | 60 | 2013 | 2421 | 2.000 |
Why?
|
| Evolution, Molecular | 41 | 2016 | 1940 | 1.730 |
Why?
|
| Genetic Diseases, Inborn | 17 | 2021 | 587 | 1.710 |
Why?
|
| Sequence Analysis, DNA | 63 | 2018 | 4803 | 1.610 |
Why?
|
| Genetic Variation | 48 | 2021 | 6544 | 1.470 |
Why?
|
| Genetics, Medical | 11 | 2021 | 338 | 1.420 |
Why?
|
| Haplotypes | 39 | 2023 | 2779 | 1.280 |
Why?
|
| Genes | 22 | 2017 | 1893 | 1.280 |
Why?
|
| Genetics, Population | 16 | 2020 | 934 | 1.210 |
Why?
|
| Conserved Sequence | 25 | 2017 | 1202 | 1.210 |
Why?
|
| Mutation | 92 | 2020 | 29786 | 1.170 |
Why?
|
| Genetic Techniques | 15 | 2016 | 435 | 1.160 |
Why?
|
| Genetic Predisposition to Disease | 47 | 2024 | 17446 | 1.150 |
Why?
|
| Gene Expression Regulation | 31 | 2022 | 12072 | 1.150 |
Why?
|
| Chromosomes | 12 | 2017 | 596 | 1.130 |
Why?
|
| Polymorphism, Genetic | 41 | 2022 | 4328 | 1.110 |
Why?
|
| Models, Genetic | 42 | 2019 | 3494 | 1.080 |
Why?
|
| Genome-Wide Association Study | 36 | 2024 | 12261 | 1.070 |
Why?
|
| Transcription Factors | 40 | 2022 | 12208 | 1.060 |
Why?
|
| Disease | 8 | 2020 | 680 | 1.060 |
Why?
|
| Genetic Engineering | 7 | 2023 | 951 | 1.050 |
Why?
|
| Selection, Genetic | 19 | 2020 | 914 | 1.040 |
Why?
|
| Chromatin | 24 | 2016 | 2934 | 0.990 |
Why?
|
| Multifactorial Inheritance | 9 | 2024 | 1194 | 0.990 |
Why?
|
| Enhancer Elements, Genetic | 10 | 2022 | 1341 | 0.960 |
Why?
|
| Base Sequence | 64 | 2018 | 12797 | 0.960 |
Why?
|
| Gene Expression Profiling | 47 | 2021 | 9438 | 0.950 |
Why?
|
| High-Throughput Nucleotide Sequencing | 21 | 2020 | 3597 | 0.910 |
Why?
|
| Gene Library | 21 | 2016 | 1074 | 0.900 |
Why?
|
| RNA, Untranslated | 12 | 2014 | 453 | 0.900 |
Why?
|
| Molecular Sequence Data | 72 | 2016 | 18111 | 0.840 |
Why?
|
| Genome, Fungal | 9 | 2013 | 204 | 0.810 |
Why?
|
| Linkage Disequilibrium | 21 | 2023 | 1997 | 0.800 |
Why?
|
| RNA | 12 | 2022 | 2749 | 0.790 |
Why?
|
| Gene Knockout Techniques | 6 | 2019 | 809 | 0.780 |
Why?
|
| Physical Chromosome Mapping | 14 | 2008 | 183 | 0.760 |
Why?
|
| Mice | 128 | 2021 | 81183 | 0.760 |
Why?
|
| Polymorphism, Single Nucleotide | 54 | 2024 | 15519 | 0.750 |
Why?
|
| Genetic Testing | 15 | 2020 | 3444 | 0.750 |
Why?
|
| Alleles | 44 | 2023 | 6933 | 0.740 |
Why?
|
| Mammals | 11 | 2016 | 1143 | 0.740 |
Why?
|
| Animals | 209 | 2021 | 168757 | 0.720 |
Why?
|
| Genomic Instability | 3 | 2018 | 695 | 0.710 |
Why?
|
| Genes, Neoplasm | 6 | 2017 | 376 | 0.710 |
Why?
|
| Saccharomyces | 6 | 2013 | 65 | 0.700 |
Why?
|
| Promoter Regions, Genetic | 14 | 2022 | 5867 | 0.690 |
Why?
|
| Genetic Markers | 42 | 2005 | 2634 | 0.690 |
Why?
|
| Pyrans | 2 | 2009 | 54 | 0.690 |
Why?
|
| Response Elements | 3 | 2018 | 312 | 0.680 |
Why?
|
| Prion Diseases | 1 | 2020 | 88 | 0.670 |
Why?
|
| Transcription, Genetic | 28 | 2018 | 7722 | 0.660 |
Why?
|
| Chromosomes, Artificial, Yeast | 7 | 1999 | 118 | 0.650 |
Why?
|
| Anemia, Diamond-Blackfan | 5 | 2018 | 137 | 0.650 |
Why?
|
| Heredity | 1 | 2019 | 154 | 0.650 |
Why?
|
| Monocarboxylic Acid Transporters | 2 | 2019 | 80 | 0.640 |
Why?
|
| Humans | 405 | 2024 | 744343 | 0.640 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2018 | 102 | 0.640 |
Why?
|
| DNA | 26 | 2016 | 7301 | 0.620 |
Why?
|
| Single-Cell Analysis | 5 | 2023 | 2183 | 0.610 |
Why?
|
| Microsatellite Repeats | 13 | 2016 | 802 | 0.600 |
Why?
|
| Sequence Alignment | 21 | 2013 | 2256 | 0.590 |
Why?
|
| Quantitative Trait Loci | 15 | 2023 | 2019 | 0.590 |
Why?
|
| Genetic Loci | 9 | 2021 | 2575 | 0.590 |
Why?
|
| Chromosomes, Mammalian | 8 | 2010 | 151 | 0.590 |
Why?
|
| Germ-Line Mutation | 9 | 2020 | 1788 | 0.590 |
Why?
|
| RNA, Messenger | 28 | 2022 | 13033 | 0.580 |
Why?
|
| Neoplastic Stem Cells | 7 | 2013 | 1376 | 0.580 |
Why?
|
| RNA-Binding Proteins | 6 | 2020 | 1903 | 0.580 |
Why?
|
| Gene Frequency | 22 | 2023 | 3588 | 0.570 |
Why?
|
| Software | 28 | 2020 | 4443 | 0.560 |
Why?
|
| Laboratory Personnel | 1 | 2016 | 19 | 0.550 |
Why?
|
| Ribosomes | 4 | 2020 | 500 | 0.550 |
Why?
|
| Pluripotent Stem Cells | 5 | 2011 | 795 | 0.540 |
Why?
|
| Contig Mapping | 6 | 2017 | 54 | 0.540 |
Why?
|
| Osteochondrodysplasias | 5 | 1999 | 183 | 0.530 |
Why?
|
| Dogs | 11 | 2015 | 3912 | 0.520 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 | 2017 | 1596 | 0.520 |
Why?
|
| International Cooperation | 4 | 2019 | 1420 | 0.510 |
Why?
|
| Neoplasms | 29 | 2020 | 21683 | 0.500 |
Why?
|
| Heterozygote | 18 | 2017 | 2804 | 0.490 |
Why?
|
| Consensus Sequence | 2 | 2007 | 377 | 0.490 |
Why?
|
| Crosses, Genetic | 25 | 2010 | 791 | 0.490 |
Why?
|
| Exons | 21 | 2018 | 2437 | 0.490 |
Why?
|
| DNA Mutational Analysis | 20 | 2020 | 4186 | 0.490 |
Why?
|
| Nucleic Acid Conformation | 6 | 2017 | 913 | 0.490 |
Why?
|
| Awards and Prizes | 1 | 2019 | 375 | 0.480 |
Why?
|
| Gene Duplication | 8 | 2014 | 329 | 0.480 |
Why?
|
| Phylogeny | 23 | 2017 | 2803 | 0.480 |
Why?
|
| Polymorphism, Restriction Fragment Length | 16 | 1993 | 768 | 0.480 |
Why?
|
| Neoplasm Proteins | 8 | 2019 | 3703 | 0.470 |
Why?
|
| Repressor Proteins | 11 | 2020 | 3023 | 0.470 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 31 | 2014 | 3920 | 0.470 |
Why?
|
| Genotype | 45 | 2018 | 12951 | 0.460 |
Why?
|
| Algorithms | 30 | 2022 | 13881 | 0.460 |
Why?
|
| Gene Dosage | 11 | 2020 | 1252 | 0.460 |
Why?
|
| Open Reading Frames | 8 | 2011 | 810 | 0.460 |
Why?
|
| Computational Biology | 20 | 2020 | 3521 | 0.460 |
Why?
|
| RNA Splicing | 3 | 2016 | 907 | 0.460 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2010 | 544 | 0.450 |
Why?
|
| Lassa Fever | 3 | 2024 | 97 | 0.440 |
Why?
|
| DNA-Binding Proteins | 19 | 2020 | 9648 | 0.440 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 6 | 2018 | 794 | 0.440 |
Why?
|
| Cloning, Molecular | 22 | 2008 | 4320 | 0.440 |
Why?
|
| Intestinal Neoplasms | 6 | 1997 | 319 | 0.430 |
Why?
|
| History, 21st Century | 6 | 2021 | 1534 | 0.430 |
Why?
|
| Histones | 13 | 2015 | 2599 | 0.430 |
Why?
|
| DNA Methylation | 17 | 2018 | 4286 | 0.420 |
Why?
|
| Epigenesis, Genetic | 12 | 2020 | 3647 | 0.420 |
Why?
|
| Mathematics | 5 | 2010 | 728 | 0.410 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 1119 | 0.410 |
Why?
|
| DNA Transposable Elements | 8 | 2019 | 748 | 0.410 |
Why?
|
| Markov Chains | 4 | 2011 | 969 | 0.410 |
Why?
|
| Cell Differentiation | 15 | 2023 | 11483 | 0.410 |
Why?
|
| Saccharomyces cerevisiae | 14 | 2014 | 2752 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2021 | 11725 | 0.400 |
Why?
|
| Gene Deletion | 9 | 2019 | 2751 | 0.390 |
Why?
|
| Biological Evolution | 11 | 2015 | 1076 | 0.390 |
Why?
|
| Proteins | 11 | 2020 | 6103 | 0.390 |
Why?
|
| Synteny | 11 | 2011 | 79 | 0.390 |
Why?
|
| Gene Knockdown Techniques | 8 | 2017 | 1655 | 0.390 |
Why?
|
| Bacteria | 5 | 2016 | 2114 | 0.390 |
Why?
|
| Recombination, Genetic | 17 | 2012 | 1586 | 0.390 |
Why?
|
| CpG Islands | 10 | 2014 | 1172 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 20 | 2017 | 8428 | 0.380 |
Why?
|
| Antigens, Neoplasm | 5 | 2018 | 1988 | 0.380 |
Why?
|
| Bacteroides | 3 | 2020 | 161 | 0.370 |
Why?
|
| Phospholipases A | 3 | 2001 | 216 | 0.370 |
Why?
|
| History, 20th Century | 7 | 2021 | 2740 | 0.370 |
Why?
|
| Lod Score | 18 | 2002 | 614 | 0.370 |
Why?
|
| Government Regulation | 1 | 2015 | 522 | 0.370 |
Why?
|
| Engineering | 1 | 2010 | 58 | 0.370 |
Why?
|
| Phenotype | 39 | 2023 | 16365 | 0.370 |
Why?
|
| Binding Sites | 13 | 2020 | 6114 | 0.360 |
Why?
|
| Genetic Code | 3 | 2007 | 154 | 0.360 |
Why?
|
| Sequence Analysis, RNA | 9 | 2019 | 2012 | 0.360 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2009 | 520 | 0.360 |
Why?
|
| Receptors, LDL | 4 | 2018 | 475 | 0.360 |
Why?
|
| Genetic Research | 1 | 2011 | 174 | 0.360 |
Why?
|
| Gene Expression | 20 | 2020 | 7799 | 0.360 |
Why?
|
| Chromosomes, Human | 9 | 2009 | 457 | 0.350 |
Why?
|
| Cell Nucleus | 6 | 2018 | 2969 | 0.350 |
Why?
|
| Embryonic Stem Cells | 10 | 2019 | 1294 | 0.350 |
Why?
|
| DNA Fingerprinting | 4 | 2003 | 112 | 0.350 |
Why?
|
| Founder Effect | 5 | 2001 | 189 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2019 | 3617 | 0.350 |
Why?
|
| Genome, Bacterial | 4 | 2019 | 760 | 0.340 |
Why?
|
| Databases, Genetic | 8 | 2014 | 1783 | 0.340 |
Why?
|
| Molecular Biology | 3 | 2021 | 596 | 0.340 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2015 | 635 | 0.340 |
Why?
|
| Point Mutation | 10 | 2015 | 1623 | 0.330 |
Why?
|
| Genes, Fungal | 5 | 2011 | 455 | 0.330 |
Why?
|
| Hyperlipoproteinemia Type II | 3 | 2019 | 373 | 0.330 |
Why?
|
| Carrier Proteins | 13 | 2017 | 5021 | 0.330 |
Why?
|
| DNA, Neoplasm | 7 | 2015 | 1758 | 0.320 |
Why?
|
| GATA1 Transcription Factor | 5 | 2019 | 293 | 0.320 |
Why?
|
| Sulfates | 4 | 1996 | 390 | 0.320 |
Why?
|
| Genes, Tumor Suppressor | 8 | 2010 | 1097 | 0.320 |
Why?
|
| Technology | 1 | 2010 | 305 | 0.310 |
Why?
|
| Polymerase Chain Reaction | 24 | 2014 | 6171 | 0.310 |
Why?
|
| Mice, Inbred Strains | 8 | 2006 | 1827 | 0.310 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2013 | 730 | 0.310 |
Why?
|
| Science | 1 | 2010 | 241 | 0.310 |
Why?
|
| Multigene Family | 13 | 2010 | 1102 | 0.310 |
Why?
|
| Social Change | 2 | 2019 | 153 | 0.310 |
Why?
|
| Nucleic Acid Hybridization | 9 | 2020 | 1375 | 0.300 |
Why?
|
| Leptotrichia | 2 | 2017 | 12 | 0.300 |
Why?
|
| Insulator Elements | 1 | 2007 | 27 | 0.300 |
Why?
|
| Breast Neoplasms | 16 | 2020 | 20822 | 0.300 |
Why?
|
| Mice, Neurologic Mutants | 3 | 2001 | 126 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 5 | 7 | 2004 | 403 | 0.300 |
Why?
|
| X Chromosome | 7 | 2015 | 814 | 0.300 |
Why?
|
| Genetics | 2 | 2000 | 112 | 0.300 |
Why?
|
| Models, Biological | 4 | 2022 | 9583 | 0.300 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2015 | 871 | 0.290 |
Why?
|
| Homozygote | 12 | 2017 | 1785 | 0.290 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1353 | 0.290 |
Why?
|
| X Chromosome Inactivation | 5 | 2016 | 224 | 0.290 |
Why?
|
| Urochordata | 2 | 2005 | 21 | 0.290 |
Why?
|
| Pedigree | 22 | 2017 | 4644 | 0.290 |
Why?
|
| Consanguinity | 7 | 2017 | 454 | 0.280 |
Why?
|
| Mice, Inbred A | 4 | 2004 | 248 | 0.280 |
Why?
|
| Signal Transduction | 30 | 2024 | 23403 | 0.280 |
Why?
|
| RNA Splice Sites | 3 | 2017 | 209 | 0.280 |
Why?
|
| Female | 139 | 2022 | 380194 | 0.280 |
Why?
|
| Sequence Tagged Sites | 8 | 2002 | 94 | 0.280 |
Why?
|
| Genomic Library | 5 | 2015 | 193 | 0.280 |
Why?
|
| Male | 130 | 2021 | 350118 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2005 | 230 | 0.270 |
Why?
|
| Methylation | 10 | 2014 | 1106 | 0.270 |
Why?
|
| Amino Acid Sequence | 19 | 2017 | 13815 | 0.270 |
Why?
|
| Genes, Recessive | 6 | 2001 | 641 | 0.270 |
Why?
|
| DNA, Complementary | 14 | 2003 | 2050 | 0.270 |
Why?
|
| Cancer Vaccines | 4 | 2018 | 1023 | 0.270 |
Why?
|
| Mass Spectrometry | 4 | 2018 | 2203 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2002 | 462 | 0.270 |
Why?
|
| Cell Line, Tumor | 27 | 2020 | 16689 | 0.260 |
Why?
|
| Gene Expression Regulation, Fungal | 7 | 2004 | 502 | 0.260 |
Why?
|
| Mutagenesis | 8 | 2012 | 1266 | 0.260 |
Why?
|
| Adenocarcinoma | 11 | 2015 | 6364 | 0.260 |
Why?
|
| Receptors, CCR5 | 2 | 2016 | 497 | 0.260 |
Why?
|
| Hemangiosarcoma | 2 | 2020 | 239 | 0.260 |
Why?
|
| Membrane Proteins | 13 | 2016 | 7880 | 0.260 |
Why?
|
| Gene Regulatory Networks | 6 | 2022 | 1708 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 245 | 0.250 |
Why?
|
| Species Specificity | 9 | 2017 | 2478 | 0.250 |
Why?
|
| 5' Untranslated Regions | 3 | 2018 | 249 | 0.250 |
Why?
|
| Sequence Homology | 3 | 2008 | 203 | 0.250 |
Why?
|
| Inbreeding | 4 | 2004 | 49 | 0.250 |
Why?
|
| Protein Binding | 9 | 2018 | 9386 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2005 | 351 | 0.250 |
Why?
|
| Research Design | 5 | 2015 | 5987 | 0.250 |
Why?
|
| DNA Probes | 4 | 2020 | 560 | 0.250 |
Why?
|
| Cell Line | 21 | 2021 | 15997 | 0.250 |
Why?
|
| Cells, Cultured | 19 | 2021 | 19229 | 0.240 |
Why?
|
| K562 Cells | 8 | 2020 | 634 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2019 | 1736 | 0.240 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 2 | 2003 | 14 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 26 | 2021 | 21827 | 0.240 |
Why?
|
| Amino Acid Motifs | 4 | 2012 | 936 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2006 | 460 | 0.240 |
Why?
|
| Hematopoietic Stem Cells | 8 | 2023 | 3386 | 0.230 |
Why?
|
| Genetic Association Studies | 7 | 2023 | 2703 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 17 | 6 | 2017 | 437 | 0.230 |
Why?
|
| Hematopoiesis | 6 | 2023 | 2072 | 0.230 |
Why?
|
| Gene Pool | 2 | 2019 | 35 | 0.230 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 2 | 2016 | 168 | 0.230 |
Why?
|
| DNA Copy Number Variations | 9 | 2018 | 1941 | 0.230 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 56 | 0.230 |
Why?
|
| Finland | 11 | 2004 | 602 | 0.230 |
Why?
|
| Homeodomain Proteins | 7 | 2012 | 2421 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 2011 | 197 | 0.220 |
Why?
|
| Lentivirus | 3 | 2016 | 501 | 0.220 |
Why?
|
| Mutation, Missense | 7 | 2018 | 2564 | 0.220 |
Why?
|
| Expressed Sequence Tags | 9 | 2008 | 255 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2017 | 5172 | 0.220 |
Why?
|
| Introns | 6 | 2020 | 991 | 0.220 |
Why?
|
| Hypercholesterolemia | 2 | 2022 | 1151 | 0.220 |
Why?
|
| Genome, Insect | 2 | 2017 | 102 | 0.210 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 2006 | 1085 | 0.210 |
Why?
|
| Coronary Artery Disease | 7 | 2024 | 6487 | 0.210 |
Why?
|
| Small Molecule Libraries | 3 | 2019 | 720 | 0.210 |
Why?
|
| Colorectal Neoplasms | 6 | 2020 | 6773 | 0.210 |
Why?
|
| Computer Simulation | 12 | 2022 | 6196 | 0.210 |
Why?
|
| RNA Interference | 12 | 2019 | 2889 | 0.210 |
Why?
|
| Gene Silencing | 4 | 2017 | 1538 | 0.210 |
Why?
|
| Mucin-1 | 3 | 2019 | 543 | 0.210 |
Why?
|
| 3T3-L1 Cells | 2 | 2017 | 198 | 0.210 |
Why?
|
| Genes, APC | 3 | 1997 | 159 | 0.210 |
Why?
|
| Genes, Reporter | 3 | 2017 | 1547 | 0.210 |
Why?
|
| Lassa virus | 3 | 2024 | 97 | 0.210 |
Why?
|
| Oncogenes | 6 | 2013 | 1265 | 0.210 |
Why?
|
| Rats | 28 | 2017 | 24260 | 0.210 |
Why?
|
| Reproducibility of Results | 23 | 2019 | 19905 | 0.210 |
Why?
|
| Paclitaxel | 1 | 2009 | 1708 | 0.210 |
Why?
|
| Histone Code | 3 | 2017 | 163 | 0.200 |
Why?
|
| Chromosome Aberrations | 4 | 2013 | 1813 | 0.200 |
Why?
|
| Embryo, Mammalian | 4 | 2019 | 1701 | 0.200 |
Why?
|
| Haemophilus influenzae | 1 | 2002 | 171 | 0.200 |
Why?
|
| Cell Cycle | 5 | 2018 | 2967 | 0.200 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 2 | 1999 | 87 | 0.200 |
Why?
|
| Oncogene Proteins | 3 | 2015 | 749 | 0.200 |
Why?
|
| Protein Biosynthesis | 6 | 2020 | 2126 | 0.200 |
Why?
|
| Lymphopenia | 5 | 2004 | 285 | 0.200 |
Why?
|
| Genetic Speciation | 2 | 2014 | 46 | 0.190 |
Why?
|
| Genes, Essential | 3 | 2019 | 183 | 0.190 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 2015 | 436 | 0.190 |
Why?
|
| Fibroblasts | 8 | 2019 | 4161 | 0.190 |
Why?
|
| Plasmodium falciparum | 5 | 2011 | 1732 | 0.190 |
Why?
|
| Stem Cells | 7 | 2021 | 3567 | 0.190 |
Why?
|
| Intestinal Polyps | 1 | 2001 | 100 | 0.190 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 713 | 0.190 |
Why?
|
| Eukaryotic Cells | 4 | 2017 | 198 | 0.190 |
Why?
|
| DNA, Intergenic | 3 | 2010 | 107 | 0.190 |
Why?
|
| Cell Cycle Proteins | 6 | 2018 | 3462 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2015 | 2938 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 7 | 2019 | 6314 | 0.190 |
Why?
|
| Molecular Probe Techniques | 2 | 1999 | 119 | 0.190 |
Why?
|
| Disease Outbreaks | 4 | 2014 | 1772 | 0.190 |
Why?
|
| 3' Untranslated Regions | 4 | 2013 | 513 | 0.180 |
Why?
|
| Chromosome Deletion | 6 | 2011 | 1401 | 0.180 |
Why?
|
| Chromosome Walking | 1 | 1999 | 27 | 0.180 |
Why?
|
| Major Histocompatibility Complex | 5 | 2007 | 936 | 0.180 |
Why?
|
| Genetic Heterogeneity | 5 | 2015 | 733 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2021 | 2425 | 0.180 |
Why?
|
| Hemorrhagic Fever, Ebola | 3 | 2015 | 428 | 0.180 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 329 | 0.180 |
Why?
|
| Models, Molecular | 8 | 2017 | 5456 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2002 | 535 | 0.180 |
Why?
|
| RNA, Small Interfering | 9 | 2019 | 3505 | 0.180 |
Why?
|
| Heptanes | 1 | 2019 | 8 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 3 | 2014 | 1364 | 0.180 |
Why?
|
| DNA Repair Enzymes | 2 | 2018 | 349 | 0.180 |
Why?
|
| Coronary Disease | 5 | 2017 | 6077 | 0.180 |
Why?
|
| Genes, Overlapping | 1 | 1999 | 36 | 0.180 |
Why?
|
| Nuclear Family | 5 | 2000 | 318 | 0.180 |
Why?
|
| Melanoma | 7 | 2017 | 5510 | 0.180 |
Why?
|
| RNA, Viral | 2 | 2020 | 2902 | 0.180 |
Why?
|
| Nucleotides | 3 | 2020 | 464 | 0.170 |
Why?
|
| Dog Diseases | 2 | 2013 | 138 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2021 | 4751 | 0.170 |
Why?
|
| Probability | 8 | 2015 | 2505 | 0.170 |
Why?
|
| Fossils | 2 | 2010 | 76 | 0.170 |
Why?
|
| Ribonucleoproteins | 2 | 2020 | 381 | 0.170 |
Why?
|
| Apolipoprotein B-100 | 2 | 2018 | 148 | 0.170 |
Why?
|
| Nuclear Proteins | 9 | 2018 | 5853 | 0.170 |
Why?
|
| Nucleotide Mapping | 2 | 1989 | 20 | 0.170 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 1465 | 0.170 |
Why?
|
| Databases, Factual | 11 | 2019 | 7729 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 7 | 2009 | 798 | 0.170 |
Why?
|
| Paternity | 1 | 1998 | 16 | 0.170 |
Why?
|
| Genes, Immediate-Early | 1 | 1999 | 101 | 0.170 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 180 | 0.170 |
Why?
|
| Cluster Analysis | 11 | 2020 | 2715 | 0.170 |
Why?
|
| Mice, SCID | 5 | 2011 | 2716 | 0.170 |
Why?
|
| Base Composition | 7 | 2012 | 293 | 0.170 |
Why?
|
| Penetrance | 1 | 2020 | 381 | 0.160 |
Why?
|
| Indazoles | 2 | 2017 | 289 | 0.160 |
Why?
|
| RNA, Neoplasm | 4 | 2013 | 769 | 0.160 |
Why?
|
| Deoxyribonucleotides | 1 | 1998 | 42 | 0.160 |
Why?
|
| Extremities | 3 | 2013 | 865 | 0.160 |
Why?
|
| Bone Diseases, Developmental | 1 | 1999 | 130 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 8 | 2014 | 1888 | 0.160 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2018 | 70 | 0.160 |
Why?
|
| Osteosarcoma | 2 | 2014 | 881 | 0.160 |
Why?
|
| beta Catenin | 3 | 2014 | 1059 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 2077 | 0.160 |
Why?
|
| Genes, Insect | 2 | 2010 | 268 | 0.160 |
Why?
|
| Escherichia coli Infections | 2 | 2012 | 532 | 0.160 |
Why?
|
| Glioblastoma | 5 | 2018 | 3481 | 0.160 |
Why?
|
| Prions | 1 | 2020 | 180 | 0.160 |
Why?
|
| Ruminococcus | 1 | 2017 | 12 | 0.160 |
Why?
|
| Ovum | 1 | 2019 | 189 | 0.160 |
Why?
|
| Escherichia coli | 7 | 2017 | 4217 | 0.160 |
Why?
|
| Mice, Inbred NOD | 4 | 2011 | 1878 | 0.160 |
Why?
|
| Fungal Proteins | 5 | 2003 | 912 | 0.160 |
Why?
|
| U937 Cells | 1 | 2018 | 268 | 0.160 |
Why?
|
| Cell Survival | 7 | 2018 | 5882 | 0.160 |
Why?
|
| Somites | 1 | 1998 | 62 | 0.160 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2013 | 3143 | 0.160 |
Why?
|
| Cholesterol, LDL | 6 | 2019 | 2356 | 0.160 |
Why?
|
| Human Body | 1 | 2017 | 39 | 0.150 |
Why?
|
| Pseudogenes | 4 | 2007 | 113 | 0.150 |
Why?
|
| Models, Statistical | 7 | 2019 | 5102 | 0.150 |
Why?
|
| Genes, p53 | 3 | 2015 | 755 | 0.150 |
Why?
|
| Glycosyltransferases | 1 | 1998 | 113 | 0.150 |
Why?
|
| Drug Resistance, Microbial | 3 | 2019 | 862 | 0.150 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 604 | 0.150 |
Why?
|
| Jurkat Cells | 2 | 2018 | 743 | 0.150 |
Why?
|
| Famous Persons | 1 | 1998 | 108 | 0.150 |
Why?
|
| Translocation, Genetic | 4 | 2012 | 1420 | 0.150 |
Why?
|
| Ebolavirus | 3 | 2015 | 263 | 0.150 |
Why?
|
| Hypertension, Renal | 1 | 2017 | 177 | 0.150 |
Why?
|
| Case-Control Studies | 16 | 2020 | 21746 | 0.150 |
Why?
|
| Syndactyly | 1 | 1997 | 72 | 0.150 |
Why?
|
| Leukemia, Myeloid | 2 | 2001 | 707 | 0.150 |
Why?
|
| TRPC Cation Channels | 1 | 2017 | 121 | 0.150 |
Why?
|
| Neoplasm Transplantation | 3 | 2011 | 2085 | 0.150 |
Why?
|
| Animals, Domestic | 2 | 2014 | 56 | 0.150 |
Why?
|
| DNA Damage | 3 | 2018 | 2432 | 0.150 |
Why?
|
| Chromosome Segregation | 1 | 2018 | 235 | 0.150 |
Why?
|
| Tumor Suppressor Protein p53 | 7 | 2020 | 2948 | 0.150 |
Why?
|
| Sequence Deletion | 10 | 2012 | 1526 | 0.140 |
Why?
|
| Body Weight | 5 | 2019 | 4669 | 0.140 |
Why?
|
| Angiopoietins | 1 | 2017 | 80 | 0.140 |
Why?
|
| Fourier Analysis | 1 | 1998 | 447 | 0.140 |
Why?
|
| Spliceosomes | 2 | 2011 | 110 | 0.140 |
Why?
|
| Chromosomes, Fungal | 3 | 1999 | 111 | 0.140 |
Why?
|
| Lipoprotein Lipase | 1 | 2017 | 126 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 377 | 0.140 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2017 | 110 | 0.140 |
Why?
|
| Haloferax mediterranei | 1 | 2016 | 3 | 0.140 |
Why?
|
| Atlases as Topic | 1 | 2017 | 236 | 0.140 |
Why?
|
| Fishes | 2 | 2013 | 569 | 0.140 |
Why?
|
| DNA Primers | 9 | 2004 | 2892 | 0.140 |
Why?
|
| Aedes | 1 | 2017 | 100 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2006 | 1519 | 0.140 |
Why?
|
| Sulfonamides | 2 | 2017 | 1938 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2017 | 170 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2020 | 2915 | 0.140 |
Why?
|
| Isoenzymes | 1 | 2001 | 1726 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2015 | 705 | 0.140 |
Why?
|
| Cell Lineage | 6 | 2016 | 2504 | 0.140 |
Why?
|
| Morals | 1 | 2019 | 284 | 0.140 |
Why?
|
| RNA, Antisense | 2 | 2015 | 138 | 0.140 |
Why?
|
| PPAR gamma | 2 | 2017 | 493 | 0.140 |
Why?
|
| Rats, Inbred SHR | 3 | 1995 | 195 | 0.130 |
Why?
|
| Vertebrates | 3 | 2013 | 227 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2019 | 1832 | 0.130 |
Why?
|
| Archaea | 1 | 2016 | 59 | 0.130 |
Why?
|
| Hominidae | 2 | 2010 | 74 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 286 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 9 | 2019 | 2649 | 0.130 |
Why?
|
| Chordata, Nonvertebrate | 2 | 2006 | 14 | 0.130 |
Why?
|
| Africa | 5 | 2020 | 673 | 0.130 |
Why?
|
| Ribosomal Proteins | 5 | 2018 | 360 | 0.130 |
Why?
|
| Proteinuria | 2 | 2017 | 658 | 0.130 |
Why?
|
| Virus Assembly | 1 | 2016 | 144 | 0.130 |
Why?
|
| Middle Aged | 44 | 2022 | 213383 | 0.130 |
Why?
|
| MicroRNAs | 7 | 2020 | 3752 | 0.130 |
Why?
|
| Tumor Escape | 1 | 2018 | 349 | 0.130 |
Why?
|
| DNA Replication | 3 | 2018 | 1399 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 736 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2015 | 2942 | 0.130 |
Why?
|
| Genes, ras | 3 | 2009 | 690 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 2109 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2020 | 553 | 0.130 |
Why?
|
| Family | 4 | 2019 | 3147 | 0.130 |
Why?
|
| Cichlids | 1 | 2014 | 11 | 0.130 |
Why?
|
| Schizophrenia | 6 | 2014 | 6882 | 0.130 |
Why?
|
| Spermatozoa | 1 | 2019 | 625 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 296 | 0.120 |
Why?
|
| United States | 16 | 2021 | 69872 | 0.120 |
Why?
|
| Body Height | 1 | 2001 | 1577 | 0.120 |
Why?
|
| Pseudouridine | 1 | 2014 | 24 | 0.120 |
Why?
|
| Neoplasms, Squamous Cell | 2 | 2013 | 96 | 0.120 |
Why?
|
| Apolipoproteins A | 1 | 2014 | 94 | 0.120 |
Why?
|
| Genome, Viral | 2 | 2015 | 667 | 0.120 |
Why?
|
| Membrane Transport Proteins | 6 | 2014 | 1028 | 0.120 |
Why?
|
| Anion Transport Proteins | 5 | 1999 | 142 | 0.120 |
Why?
|
| RNA, Small Nuclear | 1 | 2014 | 65 | 0.120 |
Why?
|
| Animals, Wild | 1 | 2014 | 90 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2013 | 2503 | 0.120 |
Why?
|
| Endoribonucleases | 1 | 2016 | 229 | 0.120 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 481 | 0.120 |
Why?
|
| Rats, Inbred BB | 6 | 2004 | 31 | 0.120 |
Why?
|
| Thioguanine | 1 | 2013 | 46 | 0.120 |
Why?
|
| Templates, Genetic | 1 | 1994 | 211 | 0.120 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2017 | 357 | 0.120 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 8037 | 0.120 |
Why?
|
| Gene Targeting | 2 | 2016 | 880 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 7 | 4 | 2001 | 322 | 0.120 |
Why?
|
| Methyltransferases | 2 | 2014 | 367 | 0.120 |
Why?
|
| Lysosomes | 1 | 2019 | 893 | 0.120 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 1583 | 0.120 |
Why?
|
| Antineoplastic Agents | 5 | 2014 | 13695 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2013 | 65 | 0.120 |
Why?
|
| Malaria | 2 | 2010 | 1239 | 0.120 |
Why?
|
| Insulinoma | 1 | 1994 | 124 | 0.120 |
Why?
|
| Bioethical Issues | 1 | 2015 | 124 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2021 | 828 | 0.120 |
Why?
|
| Immunity | 2 | 2018 | 1012 | 0.120 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 22 | 0.120 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 252 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2020 | 1534 | 0.120 |
Why?
|
| Obesity | 8 | 2019 | 12745 | 0.120 |
Why?
|
| Gene Flow | 2 | 2010 | 79 | 0.120 |
Why?
|
| Benzamides | 1 | 2019 | 1379 | 0.120 |
Why?
|
| Restriction Mapping | 3 | 1995 | 878 | 0.120 |
Why?
|
| Adenoma | 4 | 1997 | 2174 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2021 | 1534 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2006 | 3864 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2006 | 2839 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 78 | 0.110 |
Why?
|
| Hybrid Vigor | 1 | 1992 | 6 | 0.110 |
Why?
|
| Pan troglodytes | 4 | 2010 | 229 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 1877 | 0.110 |
Why?
|
| Chimera | 1 | 1994 | 485 | 0.110 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2013 | 121 | 0.110 |
Why?
|
| Genomic Imprinting | 3 | 2007 | 328 | 0.110 |
Why?
|
| Myocardial Infarction | 5 | 2019 | 11727 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2013 | 670 | 0.110 |
Why?
|
| Mediator Complex | 2 | 2012 | 109 | 0.110 |
Why?
|
| Multiple Sclerosis | 5 | 2007 | 3079 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 124 | 0.110 |
Why?
|
| Lymphoma, B-Cell | 2 | 2015 | 931 | 0.110 |
Why?
|
| DNA Repair | 3 | 2018 | 2046 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2002 | 3336 | 0.110 |
Why?
|
| RNA, Fungal | 1 | 2013 | 164 | 0.110 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2012 | 24 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2016 | 2942 | 0.110 |
Why?
|
| Carcinoid Tumor | 1 | 1994 | 235 | 0.110 |
Why?
|
| Cyclin D3 | 1 | 2012 | 55 | 0.110 |
Why?
|
| Mesoderm | 2 | 2010 | 686 | 0.110 |
Why?
|
| Codon | 3 | 2007 | 611 | 0.110 |
Why?
|
| Receptors, Cell Surface | 4 | 2003 | 2866 | 0.110 |
Why?
|
| Gene Conversion | 2 | 2004 | 71 | 0.110 |
Why?
|
| Lipoprotein(a) | 1 | 2016 | 435 | 0.110 |
Why?
|
| Extinction, Biological | 2 | 2010 | 32 | 0.110 |
Why?
|
| DNA Polymerase II | 1 | 2013 | 107 | 0.110 |
Why?
|
| Smegmamorpha | 1 | 2012 | 21 | 0.110 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 1708 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 1997 | 748 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2005 | 319 | 0.110 |
Why?
|
| Erythropoietin | 1 | 2017 | 726 | 0.110 |
Why?
|
| Ploidies | 4 | 2013 | 281 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 1998 | 792 | 0.110 |
Why?
|
| Zea mays | 1 | 1992 | 105 | 0.110 |
Why?
|
| Mice, Transgenic | 10 | 2019 | 9734 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 8 | 2016 | 3846 | 0.100 |
Why?
|
| Breeding | 5 | 2015 | 51 | 0.100 |
Why?
|
| Minisatellite Repeats | 1 | 2013 | 165 | 0.100 |
Why?
|
| Chromosome Breakage | 1 | 2012 | 173 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2013 | 1142 | 0.100 |
Why?
|
| Etoposide | 1 | 2013 | 641 | 0.100 |
Why?
|
| Blood | 1 | 2014 | 598 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 232 | 0.100 |
Why?
|
| Protein Folding | 1 | 1996 | 843 | 0.100 |
Why?
|
| Neoplasm Metastasis | 5 | 2009 | 4851 | 0.100 |
Why?
|
| Epigenomics | 2 | 2024 | 903 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2015 | 367 | 0.100 |
Why?
|
| Proteome | 6 | 2020 | 1799 | 0.100 |
Why?
|
| Trans-Activators | 3 | 2004 | 2924 | 0.100 |
Why?
|
| Oligonucleotides | 2 | 2009 | 572 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 36 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 1477 | 0.100 |
Why?
|
| Bone Neoplasms | 2 | 2014 | 2529 | 0.100 |
Why?
|
| Mitochondria | 4 | 2021 | 3520 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2017 | 1783 | 0.100 |
Why?
|
| Transgenes | 2 | 2006 | 1009 | 0.100 |
Why?
|
| Lizards | 1 | 2011 | 55 | 0.100 |
Why?
|
| Tissue Distribution | 5 | 2006 | 2327 | 0.100 |
Why?
|
| Acetylation | 3 | 2015 | 1085 | 0.100 |
Why?
|
| Meiosis | 1 | 2013 | 339 | 0.100 |
Why?
|
| Hydrazones | 1 | 2012 | 102 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 1219 | 0.100 |
Why?
|
| Adult | 37 | 2022 | 214055 | 0.100 |
Why?
|
| Risk Factors | 18 | 2021 | 72290 | 0.100 |
Why?
|
| Cross-Linking Reagents | 1 | 2014 | 694 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.100 |
Why?
|
| Sulfites | 2 | 2014 | 79 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 602 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2017 | 1086 | 0.100 |
Why?
|
| Information Storage and Retrieval | 2 | 2011 | 824 | 0.100 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 154 | 0.100 |
Why?
|
| Barrett Esophagus | 1 | 2015 | 494 | 0.100 |
Why?
|
| Chickens | 3 | 2011 | 865 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.100 |
Why?
|
| Birds | 1 | 2011 | 163 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3479 | 0.100 |
Why?
|
| Antitubercular Agents | 1 | 2019 | 1320 | 0.100 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 1284 | 0.100 |
Why?
|
| Apoptosis | 9 | 2016 | 9727 | 0.100 |
Why?
|
| Indoles | 2 | 2017 | 1839 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 1061 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2011 | 78 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 4 | 2011 | 2716 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2017 | 9239 | 0.090 |
Why?
|
| Anxiety | 2 | 2004 | 4297 | 0.090 |
Why?
|
| Substrate Specificity | 4 | 2019 | 1801 | 0.090 |
Why?
|
| Autoimmune Diseases | 2 | 2020 | 2133 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2012 | 1312 | 0.090 |
Why?
|
| Chromosome Positioning | 1 | 2010 | 18 | 0.090 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2012 | 157 | 0.090 |
Why?
|
| Ultraviolet Rays | 2 | 2012 | 1060 | 0.090 |
Why?
|
| DNA Mismatch Repair | 1 | 2013 | 426 | 0.090 |
Why?
|
| Patient Participation | 1 | 2020 | 1457 | 0.090 |
Why?
|
| Body Patterning | 2 | 2006 | 626 | 0.090 |
Why?
|
| Aged | 29 | 2022 | 163280 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2017 | 1211 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6386 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2011 | 344 | 0.090 |
Why?
|
| Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
| Epistasis, Genetic | 2 | 2008 | 365 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 728 | 0.090 |
Why?
|
| Lung Neoplasms | 11 | 2013 | 13102 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 1246 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2006 | 373 | 0.090 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2010 | 63 | 0.090 |
Why?
|
| Lipids | 2 | 2018 | 3305 | 0.090 |
Why?
|
| Rabbits | 2 | 2014 | 4894 | 0.090 |
Why?
|
| Rats, Inbred F344 | 7 | 2004 | 862 | 0.090 |
Why?
|
| Genetic Vectors | 5 | 2006 | 3420 | 0.090 |
Why?
|
| Insect Vectors | 1 | 2010 | 134 | 0.090 |
Why?
|
| Amides | 1 | 2013 | 459 | 0.090 |
Why?
|
| Online Systems | 1 | 2011 | 184 | 0.090 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2013 | 640 | 0.090 |
Why?
|
| Hybrid Cells | 3 | 2001 | 441 | 0.090 |
Why?
|
| Loss of Heterozygosity | 3 | 2018 | 684 | 0.090 |
Why?
|
| Asthma | 7 | 2005 | 6011 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 611 | 0.090 |
Why?
|
| Claudins | 1 | 2010 | 111 | 0.090 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2009 | 82 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 624 | 0.090 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1991 | 365 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2001 | 326 | 0.090 |
Why?
|
| Trisomy | 1 | 2011 | 266 | 0.090 |
Why?
|
| Europe | 5 | 2016 | 3339 | 0.090 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2014 | 651 | 0.090 |
Why?
|
| Short Interspersed Nucleotide Elements | 2 | 2006 | 40 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 5 | 2010 | 893 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2011 | 417 | 0.090 |
Why?
|
| Adenomatous Polyposis Coli Protein | 3 | 2014 | 188 | 0.090 |
Why?
|
| Diploidy | 2 | 2008 | 138 | 0.090 |
Why?
|
| Hybridization, Genetic | 2 | 2006 | 109 | 0.080 |
Why?
|
| Age of Onset | 5 | 2017 | 3271 | 0.080 |
Why?
|
| Immunity, Innate | 5 | 2006 | 2958 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2010 | 277 | 0.080 |
Why?
|
| Brain Neoplasms | 3 | 2015 | 8863 | 0.080 |
Why?
|
| Mice, Inbred AKR | 3 | 2000 | 107 | 0.080 |
Why?
|
| Down-Regulation | 4 | 2010 | 3002 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2001 | 380 | 0.080 |
Why?
|
| Forensic Medicine | 1 | 1989 | 64 | 0.080 |
Why?
|
| Bipolar Disorder | 3 | 2007 | 5027 | 0.080 |
Why?
|
| DNA, Mitochondrial | 4 | 2010 | 817 | 0.080 |
Why?
|
| Flow Cytometry | 5 | 2012 | 5974 | 0.080 |
Why?
|
| Synthetic Biology | 1 | 2011 | 179 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2004 | 970 | 0.080 |
Why?
|
| Federal Government | 1 | 2010 | 260 | 0.080 |
Why?
|
| Horses | 1 | 2009 | 304 | 0.080 |
Why?
|
| Cystic Fibrosis | 2 | 1989 | 1177 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 3 | 2020 | 528 | 0.080 |
Why?
|
| Artifacts | 3 | 2013 | 1904 | 0.080 |
Why?
|
| Prostatic Neoplasms | 5 | 2013 | 11124 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 783 | 0.080 |
Why?
|
| Biological Assay | 1 | 2012 | 652 | 0.080 |
Why?
|
| Computer Graphics | 1 | 2011 | 361 | 0.080 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 91 | 0.080 |
Why?
|
| Cell Nucleolus | 3 | 2015 | 166 | 0.080 |
Why?
|
| Elephants | 1 | 2008 | 38 | 0.080 |
Why?
|
| Reference Standards | 3 | 2020 | 1025 | 0.080 |
Why?
|
| Ataxia | 2 | 2001 | 304 | 0.080 |
Why?
|
| Erythropoiesis | 3 | 2020 | 705 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli | 3 | 2000 | 224 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 502 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 271 | 0.080 |
Why?
|
| Anopheles | 1 | 2010 | 197 | 0.080 |
Why?
|
| Fetal Hemoglobin | 1 | 2011 | 341 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1678 | 0.080 |
Why?
|
| Mice, Mutant Strains | 4 | 2010 | 1866 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
| HEK293 Cells | 5 | 2017 | 4204 | 0.080 |
Why?
|
| Estonia | 2 | 2018 | 53 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2010 | 471 | 0.080 |
Why?
|
| Matched-Pair Analysis | 4 | 2010 | 288 | 0.080 |
Why?
|
| Triglycerides | 4 | 2017 | 2454 | 0.080 |
Why?
|
| Chromosome Breakpoints | 3 | 2012 | 98 | 0.080 |
Why?
|
| Seroepidemiologic Studies | 2 | 2024 | 401 | 0.080 |
Why?
|
| Bone Density | 1 | 2021 | 3468 | 0.080 |
Why?
|
| Muscle Development | 1 | 2009 | 271 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2010 | 359 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2012 | 1378 | 0.080 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2007 | 52 | 0.080 |
Why?
|
| Opossums | 1 | 2007 | 106 | 0.080 |
Why?
|
| GC Rich Sequence | 2 | 2011 | 21 | 0.080 |
Why?
|
| DNA, Satellite | 2 | 2006 | 69 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2017 | 3748 | 0.070 |
Why?
|
| Education | 1 | 2010 | 543 | 0.070 |
Why?
|
| Wilms Tumor | 1 | 2010 | 373 | 0.070 |
Why?
|
| Purkinje Cells | 2 | 2001 | 224 | 0.070 |
Why?
|
| Chordata | 1 | 2006 | 6 | 0.070 |
Why?
|
| Liposarcoma | 1 | 2010 | 333 | 0.070 |
Why?
|
| Faculty | 1 | 2010 | 386 | 0.070 |
Why?
|
| Oxidative Phosphorylation | 3 | 2004 | 481 | 0.070 |
Why?
|
| Feces | 3 | 2018 | 1401 | 0.070 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2020 | 890 | 0.070 |
Why?
|
| Hair Color | 1 | 2007 | 136 | 0.070 |
Why?
|
| Ovarian Neoplasms | 3 | 2013 | 4838 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1584 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2014 | 808 | 0.070 |
Why?
|
| Sensitivity and Specificity | 8 | 2016 | 14722 | 0.070 |
Why?
|
| B-Lymphocytes | 3 | 2015 | 4665 | 0.070 |
Why?
|
| Glioma | 2 | 2015 | 3401 | 0.070 |
Why?
|
| Sample Size | 3 | 2016 | 845 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 780 | 0.070 |
Why?
|
| Mitochondrial Proteins | 3 | 2017 | 996 | 0.070 |
Why?
|
| Aneuploidy | 2 | 2012 | 530 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2016 | 987 | 0.070 |
Why?
|
| History, 19th Century | 2 | 2000 | 720 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 2455 | 0.070 |
Why?
|
| Organ Specificity | 4 | 2021 | 2008 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2016 | 3309 | 0.070 |
Why?
|
| Yeasts | 2 | 2001 | 285 | 0.070 |
Why?
|
| Y Chromosome | 2 | 1998 | 206 | 0.070 |
Why?
|
| Gene Amplification | 4 | 2015 | 1063 | 0.070 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 314 | 0.070 |
Why?
|
| Metalloporphyrins | 1 | 2006 | 41 | 0.070 |
Why?
|
| Defensins | 1 | 2006 | 35 | 0.070 |
Why?
|
| Rats, Mutant Strains | 2 | 1996 | 70 | 0.070 |
Why?
|
| Classification | 1 | 2006 | 129 | 0.070 |
Why?
|
| Cell Line, Transformed | 3 | 2009 | 898 | 0.070 |
Why?
|
| Information Services | 1 | 2007 | 244 | 0.070 |
Why?
|
| Zebrafish | 4 | 2006 | 2994 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 310 | 0.070 |
Why?
|
| Euchromatin | 1 | 2006 | 56 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 252 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 3 | 2017 | 1526 | 0.070 |
Why?
|
| Estrogens | 2 | 2010 | 1566 | 0.070 |
Why?
|
| Colonic Neoplasms | 3 | 2010 | 2541 | 0.070 |
Why?
|
| Genome, Protozoan | 1 | 2006 | 142 | 0.070 |
Why?
|
| Transcription Initiation Site | 3 | 2017 | 196 | 0.070 |
Why?
|
| Proto-Oncogenes | 2 | 2008 | 321 | 0.070 |
Why?
|
| Catalase | 1 | 2006 | 222 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2016 | 1972 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2006 | 169 | 0.070 |
Why?
|
| Nigeria | 2 | 2015 | 733 | 0.070 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2007 | 252 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2006 | 1150 | 0.070 |
Why?
|
| HLA-DR Antigens | 1 | 2007 | 645 | 0.070 |
Why?
|
| Candida albicans | 2 | 2014 | 394 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1681 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 2187 | 0.060 |
Why?
|
| Sequence Analysis | 2 | 2016 | 256 | 0.060 |
Why?
|
| Pyrroles | 1 | 2012 | 1146 | 0.060 |
Why?
|
| T-Lymphocytes | 4 | 2018 | 10180 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2006 | 424 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2006 | 223 | 0.060 |
Why?
|
| Mice, Nude | 5 | 2008 | 3689 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2011 | 1581 | 0.060 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2005 | 65 | 0.060 |
Why?
|
| Statistics, Nonparametric | 3 | 2014 | 2886 | 0.060 |
Why?
|
| Disease Progression | 4 | 2015 | 13284 | 0.060 |
Why?
|
| Kidney | 4 | 2020 | 7186 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2011 | 1609 | 0.060 |
Why?
|
| Cohort Studies | 10 | 2018 | 40561 | 0.060 |
Why?
|
| Nucleosomes | 2 | 2017 | 494 | 0.060 |
Why?
|
| Predictive Value of Tests | 8 | 2003 | 15076 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2013 | 1226 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2010 | 879 | 0.060 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 57776 | 0.060 |
Why?
|
| Crohn Disease | 3 | 2003 | 2303 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 3848 | 0.060 |
Why?
|
| Cell Proliferation | 7 | 2016 | 10481 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 1439 | 0.060 |
Why?
|
| Sex Determination Processes | 1 | 2004 | 58 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2020 | 4554 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 1991 | 1504 | 0.060 |
Why?
|
| Proteoglycans | 3 | 1996 | 835 | 0.060 |
Why?
|
| Gene Rearrangement | 3 | 2017 | 1179 | 0.060 |
Why?
|
| Quebec | 2 | 2001 | 134 | 0.060 |
Why?
|
| HLA-DQ Antigens | 1 | 2004 | 210 | 0.060 |
Why?
|
| Calcium Channels | 2 | 2014 | 622 | 0.060 |
Why?
|
| Carcinoma | 2 | 2011 | 2375 | 0.060 |
Why?
|
| Pharmacogenetics | 2 | 2008 | 675 | 0.060 |
Why?
|
| Antimalarials | 1 | 2011 | 905 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2017 | 237 | 0.060 |
Why?
|
| HL-60 Cells | 2 | 2022 | 365 | 0.060 |
Why?
|
| Hypertension | 3 | 1996 | 8480 | 0.060 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 87 | 0.060 |
Why?
|
| Disease Reservoirs | 2 | 2015 | 131 | 0.060 |
Why?
|
| Biotechnology | 2 | 2012 | 281 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2019 | 3690 | 0.060 |
Why?
|
| Genes, Dominant | 4 | 1999 | 880 | 0.060 |
Why?
|
| Invertebrates | 1 | 2003 | 50 | 0.060 |
Why?
|
| Neurospora crassa | 1 | 2003 | 27 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 907 | 0.060 |
Why?
|
| Infant, Newborn | 7 | 2020 | 25625 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 597 | 0.060 |
Why?
|
| HLA Antigens | 3 | 2018 | 1381 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1504 | 0.060 |
Why?
|
| Exploratory Behavior | 1 | 2004 | 270 | 0.060 |
Why?
|
| Melanocytes | 3 | 2012 | 515 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2382 | 0.060 |
Why?
|
| Malaria, Falciparum | 2 | 2011 | 1077 | 0.060 |
Why?
|
| Subtraction Technique | 2 | 2003 | 525 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2012 | 2455 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2017 | 2187 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 476 | 0.050 |
Why?
|
| RNA Polymerase II | 2 | 2015 | 551 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1832 | 0.050 |
Why?
|
| Liver | 2 | 2017 | 7474 | 0.050 |
Why?
|
| Animals, Congenic | 4 | 2003 | 27 | 0.050 |
Why?
|
| Mass Screening | 1 | 2018 | 5255 | 0.050 |
Why?
|
| Methanosarcina | 1 | 2002 | 6 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2017 | 3523 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2018 | 504 | 0.050 |
Why?
|
| Genome, Archaeal | 1 | 2002 | 18 | 0.050 |
Why?
|
| Time Factors | 7 | 2020 | 40075 | 0.050 |
Why?
|
| Sexual Maturation | 1 | 2004 | 265 | 0.050 |
Why?
|
| Sex Chromosomes | 1 | 2002 | 105 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2001 | 1660 | 0.050 |
Why?
|
| Cholesterol | 2 | 2022 | 2917 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 669 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 2 | 2016 | 211 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2004 | 317 | 0.050 |
Why?
|
| Iowa | 1 | 2002 | 101 | 0.050 |
Why?
|
| Ectoderm | 2 | 2003 | 137 | 0.050 |
Why?
|
| Insulin | 5 | 2003 | 6580 | 0.050 |
Why?
|
| Massachusetts | 2 | 2014 | 8663 | 0.050 |
Why?
|
| Rats, Inbred WKY | 2 | 1992 | 158 | 0.050 |
Why?
|
| Podocytes | 2 | 2017 | 396 | 0.050 |
Why?
|
| Mice, Inbred DBA | 2 | 2007 | 642 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2013 | 10252 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2015 | 658 | 0.050 |
Why?
|
| Kinetics | 2 | 2022 | 6473 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 1999 | 964 | 0.050 |
Why?
|
| Genes, Homeobox | 3 | 2013 | 286 | 0.050 |
Why?
|
| Dinucleoside Phosphates | 2 | 1999 | 74 | 0.050 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2001 | 21 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 2 | 2001 | 420 | 0.050 |
Why?
|
| Clone Cells | 2 | 2015 | 1692 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 927 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2021 | 46 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2003 | 1213 | 0.050 |
Why?
|
| Child, Preschool | 8 | 2018 | 41006 | 0.050 |
Why?
|
| Maryland | 1 | 2002 | 276 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2000 | 323 | 0.050 |
Why?
|
| Biological Transport | 2 | 1996 | 2118 | 0.050 |
Why?
|
| Genetic Complementation Test | 2 | 2004 | 562 | 0.050 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2002 | 207 | 0.050 |
Why?
|
| Environment | 3 | 2001 | 1124 | 0.050 |
Why?
|
| Proteomics | 3 | 2022 | 3638 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2011 | 2916 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 2245 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2019 | 23338 | 0.050 |
Why?
|
| DNA, Recombinant | 2 | 2000 | 476 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1375 | 0.050 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2002 | 166 | 0.050 |
Why?
|
| Brain | 4 | 2021 | 26385 | 0.050 |
Why?
|
| Viral Proteins | 2 | 2015 | 1900 | 0.050 |
Why?
|
| Child | 13 | 2019 | 77709 | 0.050 |
Why?
|
| Ciliary Motility Disorders | 1 | 2001 | 47 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2002 | 526 | 0.050 |
Why?
|
| Virus Replication | 2 | 2020 | 2534 | 0.050 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2013 | 186 | 0.050 |
Why?
|
| Dysostoses | 1 | 2000 | 9 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2017 | 14557 | 0.050 |
Why?
|
| Genes, BRCA1 | 2 | 2017 | 781 | 0.050 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 137 | 0.050 |
Why?
|
| Muridae | 1 | 2000 | 61 | 0.050 |
Why?
|
| Bone and Bones | 3 | 2010 | 2575 | 0.050 |
Why?
|
| Dyneins | 1 | 2001 | 123 | 0.050 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2001 | 94 | 0.050 |
Why?
|
| Oocytes | 2 | 2002 | 1187 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2021 | 287 | 0.050 |
Why?
|
| Sulfotransferases | 2 | 2016 | 151 | 0.050 |
Why?
|
| Neuregulin-1 | 1 | 2001 | 142 | 0.050 |
Why?
|
| Adolescent | 13 | 2019 | 85781 | 0.050 |
Why?
|
| Celiac Disease | 2 | 2006 | 785 | 0.050 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2000 | 43 | 0.050 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2020 | 62 | 0.050 |
Why?
|
| Dendritic Cells | 2 | 2021 | 2725 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 1007 | 0.050 |
Why?
|
| Leigh Disease | 1 | 2001 | 75 | 0.050 |
Why?
|
| Dictionaries as Topic | 1 | 1999 | 12 | 0.050 |
Why?
|
| Disease Models, Animal | 7 | 2017 | 18029 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 270 | 0.040 |
Why?
|
| Drosophila | 1 | 2007 | 1491 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 707 | 0.040 |
Why?
|
| Imidazoline Receptors | 1 | 2019 | 13 | 0.040 |
Why?
|
| Polyadenylation | 1 | 2020 | 117 | 0.040 |
Why?
|
| Cesarean Section | 2 | 2020 | 1365 | 0.040 |
Why?
|
| Nervous System | 1 | 2003 | 554 | 0.040 |
Why?
|
| Plants | 3 | 1991 | 316 | 0.040 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 1999 | 65 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 2 | 2007 | 655 | 0.040 |
Why?
|
| Alternative Splicing | 3 | 2002 | 1117 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2019 | 28 | 0.040 |
Why?
|
| Protein Conformation | 3 | 2014 | 4011 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2017 | 2043 | 0.040 |
Why?
|
| Adipocytes | 2 | 2021 | 1184 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2001 | 434 | 0.040 |
Why?
|
| HIV Infections | 2 | 2016 | 16718 | 0.040 |
Why?
|
| Mycolic Acids | 1 | 2019 | 54 | 0.040 |
Why?
|
| Colitis, Ulcerative | 2 | 2003 | 1912 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2004 | 536 | 0.040 |
Why?
|
| Heat-Shock Proteins | 2 | 2002 | 822 | 0.040 |
Why?
|
| Public Sector | 1 | 2001 | 265 | 0.040 |
Why?
|
| Infant | 8 | 2020 | 35136 | 0.040 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 87 | 0.040 |
Why?
|
| Transcription Factors, TFII | 1 | 1998 | 60 | 0.040 |
Why?
|
| Drug Design | 1 | 2004 | 1076 | 0.040 |
Why?
|
| RNA, Ribosomal | 2 | 2014 | 246 | 0.040 |
Why?
|
| DNA Gyrase | 1 | 2019 | 83 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 11524 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2002 | 558 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1897 | 0.040 |
Why?
|
| Epilepsy | 2 | 2007 | 3310 | 0.040 |
Why?
|
| Haploidy | 3 | 2008 | 136 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2000 | 293 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 316 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 187 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 458 | 0.040 |
Why?
|
| Family Health | 2 | 2001 | 1282 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1999 | 185 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 1999 | 282 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2019 | 12720 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1998 | 354 | 0.040 |
Why?
|
| Economics, Medical | 1 | 1999 | 113 | 0.040 |
Why?
|
| Ribs | 1 | 2000 | 252 | 0.040 |
Why?
|
| Meconium | 1 | 2018 | 48 | 0.040 |
Why?
|
| Genetic Determinism | 1 | 1998 | 10 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 1999 | 188 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 611 | 0.040 |
Why?
|
| Werner Syndrome | 1 | 1998 | 12 | 0.040 |
Why?
|
| Erythroid Cells | 1 | 2020 | 238 | 0.040 |
Why?
|
| Phosphoproteins | 2 | 2017 | 2440 | 0.040 |
Why?
|
| Rats, Inbred Dahl | 1 | 2017 | 35 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2003 | 126 | 0.040 |
Why?
|
| Sweden | 1 | 2001 | 1345 | 0.040 |
Why?
|
| History, 18th Century | 1 | 1998 | 214 | 0.040 |
Why?
|
| bcl-X Protein | 2 | 2010 | 411 | 0.040 |
Why?
|
| Escherichia coli Proteins | 2 | 1996 | 1050 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2001 | 337 | 0.040 |
Why?
|
| Alanine | 1 | 2000 | 572 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 708 | 0.040 |
Why?
|
| Social Problems | 1 | 1998 | 112 | 0.040 |
Why?
|
| Amino Acids | 2 | 2004 | 1736 | 0.040 |
Why?
|
| HIV | 1 | 2005 | 1604 | 0.040 |
Why?
|
| Gene Fusion | 2 | 2012 | 371 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 206 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 1998 | 53 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2017 | 72 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 1999 | 272 | 0.040 |
Why?
|
| Antioxidants | 1 | 2006 | 1663 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 1999 | 250 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2001 | 456 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.040 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1997 | 61 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 1999 | 197 | 0.040 |
Why?
|
| Macrophages | 3 | 2021 | 5655 | 0.040 |
Why?
|
| Private Sector | 1 | 2001 | 392 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 3 | 2010 | 1613 | 0.040 |
Why?
|
| Fathers | 1 | 2000 | 358 | 0.040 |
Why?
|
| Leukocyte Count | 2 | 2016 | 1588 | 0.040 |
Why?
|
| Canada | 2 | 2020 | 2065 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 901 | 0.040 |
Why?
|
| Phenylalanine | 1 | 1999 | 365 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1116 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1041 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 378 | 0.040 |
Why?
|
| NF-kappa B | 3 | 2013 | 2499 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 13989 | 0.040 |
Why?
|
| Forecasting | 2 | 2001 | 2951 | 0.040 |
Why?
|
| Culex | 1 | 2017 | 19 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1999 | 1101 | 0.040 |
Why?
|
| Neuregulins | 1 | 2017 | 35 | 0.040 |
Why?
|
| Genetic Privacy | 1 | 1998 | 60 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2022 | 1100 | 0.040 |
Why?
|
| Drug Industry | 2 | 2001 | 746 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2017 | 3701 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 399 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2019 | 233 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2021 | 981 | 0.040 |
Why?
|
| Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 2018 | 315 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 2734 | 0.040 |
Why?
|
| Mice, Congenic | 2 | 2008 | 99 | 0.040 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 1998 | 142 | 0.040 |
Why?
|
| Data Compression | 1 | 2017 | 70 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 478 | 0.040 |
Why?
|
| Retroviridae Infections | 1 | 1997 | 151 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2017 | 167 | 0.040 |
Why?
|
| Activated-Leukocyte Cell Adhesion Molecule | 1 | 2016 | 22 | 0.040 |
Why?
|
| Primates | 2 | 2012 | 545 | 0.040 |
Why?
|
| Cilia | 1 | 2001 | 466 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 546 | 0.040 |
Why?
|
| Microcomputers | 1 | 1997 | 147 | 0.040 |
Why?
|
| Blotting, Southern | 3 | 1996 | 803 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 1950 | 0.040 |
Why?
|
| E2F Transcription Factors | 1 | 2017 | 277 | 0.040 |
Why?
|
| Receptors, Erythropoietin | 1 | 2017 | 147 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 1994 | 5256 | 0.040 |
Why?
|
| Levivirus | 1 | 2016 | 13 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.040 |
Why?
|
| Cerebellar Neoplasms | 1 | 2002 | 587 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2018 | 1157 | 0.040 |
Why?
|
| Dexamethasone | 2 | 2018 | 1951 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2002 | 6256 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 161 | 0.040 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 1997 | 91 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2018 | 2513 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1676 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2000 | 8554 | 0.030 |
Why?
|
| False Positive Reactions | 2 | 2013 | 981 | 0.030 |
Why?
|
| Autoantigens | 1 | 2020 | 892 | 0.030 |
Why?
|
| Medulloblastoma | 1 | 2002 | 683 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 2924 | 0.030 |
Why?
|
| Pakistan | 1 | 2017 | 295 | 0.030 |
Why?
|
| Carcinoma, Islet Cell | 1 | 1995 | 22 | 0.030 |
Why?
|
| Fever | 1 | 2024 | 1616 | 0.030 |
Why?
|
| Phosphatidylinositols | 1 | 1997 | 291 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2020 | 9849 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2000 | 638 | 0.030 |
Why?
|
| Achondroplasia | 1 | 1996 | 26 | 0.030 |
Why?
|
| Likelihood Functions | 2 | 2000 | 1005 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2000 | 3144 | 0.030 |
Why?
|
| Histiocytic Sarcoma | 1 | 2016 | 44 | 0.030 |
Why?
|
| Young Adult | 6 | 2020 | 56430 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2171 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2727 | 0.030 |
Why?
|
| Murinae | 1 | 2015 | 18 | 0.030 |
Why?
|
| RNA Transport | 1 | 2015 | 48 | 0.030 |
Why?
|
| Rats, Nude | 1 | 1995 | 105 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2015 | 2 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2003 | 1349 | 0.030 |
Why?
|
| Apolipoprotein C-III | 1 | 2017 | 202 | 0.030 |
Why?
|
| Lipoproteins | 2 | 2017 | 878 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2001 | 1463 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2016 | 2375 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2017 | 292 | 0.030 |
Why?
|
| Base Pairing | 1 | 2015 | 141 | 0.030 |
Why?
|
| ras Proteins | 2 | 2017 | 1060 | 0.030 |
Why?
|
| Africa, Western | 1 | 2015 | 154 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 25043 | 0.030 |
Why?
|
| Bioethics | 1 | 1996 | 116 | 0.030 |
Why?
|
| Legionnaires' Disease | 1 | 1995 | 48 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2016 | 172 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3508 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 1995 | 95 | 0.030 |
Why?
|
| Neurofilament Proteins | 1 | 1997 | 318 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2002 | 4217 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 393 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2021 | 1166 | 0.030 |
Why?
|
| Fractals | 1 | 2015 | 123 | 0.030 |
Why?
|
| Cytokines | 2 | 2001 | 7322 | 0.030 |
Why?
|
| Legionella pneumophila | 1 | 1995 | 46 | 0.030 |
Why?
|
| Plastocyanin | 1 | 1994 | 1 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 1855 | 0.030 |
Why?
|
| Intramolecular Transferases | 1 | 2014 | 15 | 0.030 |
Why?
|
| Thyroiditis | 1 | 1995 | 85 | 0.030 |
Why?
|
| Tryptophan Synthase | 1 | 1994 | 9 | 0.030 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 1994 | 32 | 0.030 |
Why?
|
| Microtubules | 1 | 2001 | 1090 | 0.030 |
Why?
|
| Artificial Intelligence | 2 | 2002 | 2214 | 0.030 |
Why?
|
| Metagenomics | 1 | 2018 | 428 | 0.030 |
Why?
|
| Africa, Eastern | 1 | 2014 | 71 | 0.030 |
Why?
|
| Tyrosine | 1 | 1999 | 1461 | 0.030 |
Why?
|
| Basophils | 1 | 2016 | 389 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2002 | 1581 | 0.030 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2016 | 156 | 0.030 |
Why?
|
| Automation | 1 | 1997 | 584 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 2849 | 0.030 |
Why?
|
| Familial Mediterranean Fever | 1 | 1995 | 61 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 149 | 0.030 |
Why?
|
| Cytochrome c Group | 1 | 1994 | 128 | 0.030 |
Why?
|
| Rats, Inbred Lew | 2 | 1995 | 1162 | 0.030 |
Why?
|
| Jurisprudence | 1 | 1994 | 110 | 0.030 |
Why?
|
| Cerebellar Ataxia | 1 | 1996 | 145 | 0.030 |
Why?
|
| Tumor Virus Infections | 1 | 1997 | 452 | 0.030 |
Why?
|
| Microsatellite Instability | 1 | 2018 | 684 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2015 | 217 | 0.030 |
Why?
|
| Normal Distribution | 1 | 1995 | 280 | 0.030 |
Why?
|
| Zoonoses | 1 | 2015 | 185 | 0.030 |
Why?
|
| Genes, myc | 1 | 2015 | 399 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2016 | 458 | 0.030 |
Why?
|
| Glycine | 1 | 1997 | 671 | 0.030 |
Why?
|
| Sierra Leone | 1 | 2014 | 166 | 0.030 |
Why?
|
| Magnetics | 1 | 1997 | 606 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 690 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 618 | 0.030 |
Why?
|
| Eosinophilia | 1 | 1998 | 541 | 0.030 |
Why?
|
| Dyskeratosis Congenita | 1 | 2014 | 72 | 0.030 |
Why?
|
| Lung | 3 | 2004 | 9856 | 0.030 |
Why?
|
| tRNA Methyltransferases | 1 | 2013 | 53 | 0.030 |
Why?
|
| Fanconi Anemia | 1 | 1996 | 319 | 0.030 |
Why?
|
| Diet | 2 | 2010 | 7939 | 0.030 |
Why?
|
| Fasting | 2 | 2017 | 1593 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1999 | 859 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5221 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 528 | 0.030 |
Why?
|
| Diffusion | 1 | 2015 | 833 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2022 | 2132 | 0.030 |
Why?
|
| Age Factors | 3 | 2015 | 18370 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2015 | 2263 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 906 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2017 | 1990 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 563 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 4262 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1316 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2012 | 671 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2015 | 383 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 424 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 711 | 0.030 |
Why?
|
| Scoliosis | 1 | 2000 | 725 | 0.030 |
Why?
|
| Primate Diseases | 1 | 2012 | 15 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 117 | 0.030 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2013 | 39 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2015 | 698 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 5181 | 0.030 |
Why?
|
| Feedback | 1 | 2016 | 795 | 0.030 |
Why?
|
| Biometry | 3 | 1997 | 558 | 0.030 |
Why?
|
| Bayes Theorem | 2 | 2013 | 2309 | 0.030 |
Why?
|
| Epilepsies, Myoclonic | 1 | 1993 | 80 | 0.030 |
Why?
|
| Spine | 1 | 2000 | 1144 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 1475 | 0.030 |
Why?
|
| Viral Load | 1 | 2021 | 3299 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2012 | 45 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 1438 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 1998 | 1364 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2015 | 321 | 0.030 |
Why?
|
| Acute Disease | 2 | 2001 | 7149 | 0.030 |
Why?
|
| Folic Acid | 1 | 2019 | 1300 | 0.030 |
Why?
|
| Atrophy | 1 | 1997 | 1583 | 0.030 |
Why?
|
| Alaska | 1 | 2012 | 68 | 0.030 |
Why?
|
| Flagellin | 1 | 2013 | 125 | 0.030 |
Why?
|
| RNA Stability | 1 | 2014 | 321 | 0.030 |
Why?
|
| Fresh Water | 1 | 2012 | 83 | 0.030 |
Why?
|
| Anisotropy | 1 | 2015 | 1265 | 0.030 |
Why?
|
| Models, Theoretical | 2 | 1996 | 3589 | 0.030 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 60 | 0.030 |
Why?
|
| Politics | 1 | 1998 | 791 | 0.030 |
Why?
|
| Prognosis | 5 | 2016 | 29063 | 0.030 |
Why?
|
| Aquatic Organisms | 1 | 2012 | 48 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 289 | 0.030 |
Why?
|
| Cartilage | 1 | 1996 | 818 | 0.030 |
Why?
|
| Brain Stem | 1 | 1997 | 846 | 0.030 |
Why?
|
| Seawater | 1 | 2012 | 121 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 433 | 0.030 |
Why?
|
| Cytosine | 1 | 2013 | 216 | 0.030 |
Why?
|
| Antigens, CD | 3 | 2011 | 4026 | 0.030 |
Why?
|
| Chromosome Inversion | 1 | 2012 | 127 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 627 | 0.030 |
Why?
|
| Guanine | 1 | 2013 | 274 | 0.030 |
Why?
|
| Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
| Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 1992 | 200 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 847 | 0.020 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2010 | 13 | 0.020 |
Why?
|
| Androgens | 1 | 1999 | 1281 | 0.020 |
Why?
|
| Models, Chemical | 1 | 1993 | 626 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 1995 | 1616 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2011 | 63 | 0.020 |
Why?
|
| Internet | 3 | 2011 | 3064 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2013 | 982 | 0.020 |
Why?
|
| Goosecoid Protein | 1 | 2010 | 9 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1991 | 212 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 15 | 0.020 |
Why?
|
| Sleep | 1 | 2007 | 4623 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2282 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 4462 | 0.020 |
Why?
|
| Adenine | 1 | 2016 | 936 | 0.020 |
Why?
|
| Baseball | 1 | 2011 | 90 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 1035 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2011 | 158 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 170 | 0.020 |
Why?
|
| Neurofibromin 1 | 1 | 2012 | 196 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 1723 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1999 | 3206 | 0.020 |
Why?
|
| Disease Susceptibility | 3 | 1997 | 1782 | 0.020 |
Why?
|
| Serum Response Factor | 1 | 2010 | 81 | 0.020 |
Why?
|
| Phloroglucinol | 1 | 2010 | 6 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 215 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2010 | 31 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1998 | 1547 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 2255 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 5686 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2010 | 105 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 643 | 0.020 |
Why?
|
| Immune Evasion | 1 | 2014 | 360 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2011 | 287 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 708 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2014 | 880 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 690 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2011 | 218 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 345 | 0.020 |
Why?
|
| Research | 1 | 1999 | 1999 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 814 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.020 |
Why?
|
| Fluorenes | 1 | 2011 | 160 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2012 | 724 | 0.020 |
Why?
|
| Karyotyping | 2 | 2004 | 1243 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 2031 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 804 | 0.020 |
Why?
|
| Mothers | 1 | 2000 | 2165 | 0.020 |
Why?
|
| Robotics | 1 | 1997 | 899 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 2540 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.020 |
Why?
|
| Telomerase | 1 | 2014 | 730 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2015 | 3474 | 0.020 |
Why?
|
| Oomycetes | 1 | 1988 | 5 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 1861 | 0.020 |
Why?
|
| Chytridiomycota | 1 | 1988 | 8 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 1996 | 1005 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2011 | 296 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2009 | 242 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 315 | 0.020 |
Why?
|
| Fatty Acids | 2 | 2007 | 1809 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2015 | 63114 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 970 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1995 | 2373 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2017 | 0.020 |
Why?
|
| Neurons | 1 | 2008 | 9338 | 0.020 |
Why?
|
| Population Groups | 1 | 2010 | 209 | 0.020 |
Why?
|
| Biotinylation | 1 | 2009 | 179 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1997 | 1809 | 0.020 |
Why?
|
| Osteogenesis | 1 | 1996 | 1299 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 220 | 0.020 |
Why?
|
| Adenosine | 1 | 2013 | 825 | 0.020 |
Why?
|
| Biotin | 1 | 2009 | 254 | 0.020 |
Why?
|
| Iceland | 1 | 1988 | 183 | 0.020 |
Why?
|
| Health | 1 | 2011 | 394 | 0.020 |
Why?
|
| Duffy Blood-Group System | 1 | 1988 | 58 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 895 | 0.020 |
Why?
|
| Metagenome | 1 | 2011 | 418 | 0.020 |
Why?
|
| Causality | 1 | 1995 | 1275 | 0.020 |
Why?
|
| Campylobacter jejuni | 1 | 2008 | 26 | 0.020 |
Why?
|
| Caenorhabditis | 1 | 1988 | 39 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 170 | 0.020 |
Why?
|
| Time | 1 | 2010 | 542 | 0.020 |
Why?
|
| Data Collection | 1 | 1998 | 3341 | 0.020 |
Why?
|
| Polymers | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 1856 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2008 | 115 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 677 | 0.020 |
Why?
|
| Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
| Tricarboxylic Acids | 1 | 2007 | 29 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 1537 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2149 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1549 | 0.020 |
Why?
|
| Systems Integration | 1 | 2010 | 440 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4931 | 0.020 |
Why?
|
| Codon, Initiator | 1 | 2007 | 52 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1602 | 0.020 |
Why?
|
| Intestines | 2 | 2011 | 1924 | 0.020 |
Why?
|
| Methacholine Chloride | 2 | 1999 | 233 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 340 | 0.020 |
Why?
|
| Gene Order | 1 | 2007 | 176 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2008 | 182 | 0.020 |
Why?
|
| Ethosuximide | 1 | 2007 | 9 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2007 | 127 | 0.020 |
Why?
|
| Community Health Services | 1 | 2012 | 650 | 0.020 |
Why?
|
| England | 1 | 1988 | 522 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2014 | 1348 | 0.020 |
Why?
|
| Genome, Mitochondrial | 1 | 2007 | 71 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1988 | 393 | 0.020 |
Why?
|
| Central America | 1 | 2006 | 68 | 0.020 |
Why?
|
| Cyclins | 2 | 1999 | 603 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3129 | 0.020 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 594 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2007 | 299 | 0.020 |
Why?
|
| Blood Group Antigens | 1 | 1988 | 180 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 2007 | 134 | 0.020 |
Why?
|
| Weight Gain | 2 | 2010 | 2292 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 461 | 0.020 |
Why?
|
| Limonins | 1 | 2006 | 24 | 0.020 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2006 | 29 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2014 | 1821 | 0.020 |
Why?
|
| Phenothiazines | 1 | 2006 | 63 | 0.020 |
Why?
|
| South America | 1 | 2006 | 181 | 0.020 |
Why?
|
| Tetraodontiformes | 1 | 2006 | 12 | 0.020 |
Why?
|
| Expert Testimony | 1 | 1989 | 356 | 0.020 |
Why?
|
| Libraries | 1 | 2006 | 21 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 3086 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1997 | 1622 | 0.020 |
Why?
|
| Plasmodium | 1 | 2009 | 250 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2019 | 1912 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 1682 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 644 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2007 | 425 | 0.020 |
Why?
|
| Azacitidine | 1 | 2008 | 347 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4560 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 940 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 3798 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1881 | 0.020 |
Why?
|
| Cats | 1 | 2007 | 998 | 0.020 |
Why?
|
| Antiporters | 1 | 2007 | 277 | 0.020 |
Why?
|
| Cell Separation | 1 | 2012 | 1751 | 0.020 |
Why?
|
| Diazepam | 1 | 2007 | 205 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2006 | 51 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 2006 | 299 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2006 | 61 | 0.020 |
Why?
|
| Receptors, Notch | 2 | 2001 | 739 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2007 | 1386 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4933 | 0.020 |
Why?
|
| Endocannabinoids | 1 | 2006 | 116 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 3587 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1989 | 846 | 0.020 |
Why?
|
| Placenta | 2 | 2006 | 1698 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 682 | 0.020 |
Why?
|
| Rats, Inbred BN | 2 | 1995 | 235 | 0.020 |
Why?
|
| Hair | 1 | 2008 | 483 | 0.020 |
Why?
|
| Health Care Costs | 1 | 1999 | 3209 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 669 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 610 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2011 | 1119 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 841 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1127 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1730 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3616 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1993 | 1061 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2014 | 6459 | 0.020 |
Why?
|
| Sex Factors | 2 | 1989 | 10397 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
| Azores | 1 | 2004 | 6 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 1161 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4386 | 0.020 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2004 | 46 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
| Italy | 1 | 1986 | 832 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 1254 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2014 | 1185 | 0.020 |
Why?
|
| Sterols | 1 | 2004 | 63 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1988 | 1154 | 0.010 |
Why?
|
| Lipopolysaccharides | 2 | 2002 | 2216 | 0.010 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2006 | 338 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2007 | 574 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1996 | 2186 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 4479 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 434 | 0.010 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 1224 | 0.010 |
Why?
|
| Glycolysis | 1 | 2007 | 827 | 0.010 |
Why?
|
| Glucose | 3 | 2003 | 4397 | 0.010 |
Why?
|
| Albinism | 1 | 2002 | 25 | 0.010 |
Why?
|
| Cell Respiration | 1 | 2003 | 201 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2003 | 93 | 0.010 |
Why?
|
| Rats, Inbred LEC | 1 | 2002 | 2 | 0.010 |
Why?
|
| Rats, Inbred OLETF | 1 | 2002 | 8 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5179 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2006 | 767 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 2002 | 69 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2002 | 223 | 0.010 |
Why?
|
| Gene Expression Regulation, Archaeal | 1 | 2002 | 2 | 0.010 |
Why?
|
| Cell Division | 2 | 2001 | 4568 | 0.010 |
Why?
|
| Reproduction | 1 | 2007 | 668 | 0.010 |
Why?
|
| Euryarchaeota | 1 | 2002 | 7 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 356 | 0.010 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2002 | 19 | 0.010 |
Why?
|
| Nitrogen Fixation | 1 | 2002 | 60 | 0.010 |
Why?
|
| Diterpenes | 1 | 2003 | 173 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2002 | 91 | 0.010 |
Why?
|
| Plant Diseases | 1 | 2003 | 150 | 0.010 |
Why?
|
| India | 1 | 2008 | 2197 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9687 | 0.010 |
Why?
|
| Archaeal Proteins | 1 | 2002 | 56 | 0.010 |
Why?
|
| Replication Origin | 1 | 2002 | 77 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2002 | 65 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 455 | 0.010 |
Why?
|
| Publication Bias | 1 | 2003 | 162 | 0.010 |
Why?
|
| Australia | 1 | 2005 | 1170 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 238 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1681 | 0.010 |
Why?
|
| Teichoic Acids | 1 | 2002 | 66 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 2557 | 0.010 |
Why?
|
| Electromyography | 1 | 2007 | 1379 | 0.010 |
Why?
|
| Metalloproteins | 1 | 2002 | 100 | 0.010 |
Why?
|
| Cattle | 1 | 2007 | 3922 | 0.010 |
Why?
|
| Hydrogen | 1 | 2002 | 164 | 0.010 |
Why?
|
| Mannans | 1 | 2001 | 63 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 4034 | 0.010 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2001 | 5 | 0.010 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2001 | 26 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 3176 | 0.010 |
Why?
|
| Axonemal Dyneins | 1 | 2001 | 24 | 0.010 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2001 | 54 | 0.010 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2006 | 789 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1344 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 1105 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 838 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 2001 | 117 | 0.010 |
Why?
|
| Salts | 1 | 2001 | 65 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 2002 | 184 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2017 | 3445 | 0.010 |
Why?
|
| Cell Communication | 1 | 2008 | 1621 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2001 | 151 | 0.010 |
Why?
|
| Prevalence | 2 | 2012 | 15226 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 2001 | 189 | 0.010 |
Why?
|
| Thymosin | 1 | 2000 | 47 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 1999 | 5319 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2001 | 215 | 0.010 |
Why?
|
| Smoking | 2 | 2011 | 8987 | 0.010 |
Why?
|
| Transfection | 2 | 2004 | 5892 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2000 | 133 | 0.010 |
Why?
|
| Mycobacterium | 1 | 2002 | 249 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2001 | 321 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2002 | 270 | 0.010 |
Why?
|
| Siblings | 1 | 2004 | 854 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2001 | 290 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 1999 | 77 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2002 | 473 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2001 | 165 | 0.010 |
Why?
|
| Homeostasis | 1 | 2011 | 3340 | 0.010 |
Why?
|
| Neoplasms, Experimental | 2 | 1996 | 1276 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 895 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1999 | 227 | 0.010 |
Why?
|
| Gorilla gorilla | 1 | 1999 | 30 | 0.010 |
Why?
|
| Vincristine | 1 | 2002 | 1039 | 0.010 |
Why?
|
| Swine | 1 | 2009 | 5917 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 686 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2004 | 1267 | 0.010 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 1587 | 0.010 |
Why?
|
| Xenopus | 1 | 2001 | 712 | 0.010 |
Why?
|
| Psoriasis | 1 | 2007 | 898 | 0.010 |
Why?
|
| Enzymes | 1 | 2001 | 266 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2000 | 241 | 0.010 |
Why?
|
| Electroencephalography | 2 | 2007 | 6150 | 0.010 |
Why?
|
| Polyploidy | 1 | 1999 | 114 | 0.010 |
Why?
|
| Vagina | 1 | 2004 | 825 | 0.010 |
Why?
|
| Sirolimus | 1 | 2006 | 1564 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2001 | 294 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 1998 | 52 | 0.010 |
Why?
|
| Pheromones | 1 | 1999 | 98 | 0.010 |
Why?
|
| HIV-1 | 1 | 2016 | 6939 | 0.010 |
Why?
|
| Isochromosomes | 1 | 1998 | 16 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29144 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 2002 | 531 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2001 | 964 | 0.010 |
Why?
|
| Cytogenetics | 1 | 1999 | 203 | 0.010 |
Why?
|
| SOX9 Transcription Factor | 1 | 1999 | 146 | 0.010 |
Why?
|
| RNA Helicases | 1 | 1999 | 142 | 0.010 |
Why?
|
| Genes, cdc | 1 | 1998 | 116 | 0.010 |
Why?
|
| Wound Healing | 1 | 2009 | 2785 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 721 | 0.010 |
Why?
|
| Access to Information | 1 | 2001 | 320 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 1703 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 1998 | 151 | 0.010 |
Why?
|
| Jews | 1 | 2000 | 385 | 0.010 |
Why?
|
| Integrases | 1 | 2001 | 533 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 2362 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 273 | 0.010 |
Why?
|
| G1 Phase | 1 | 1999 | 415 | 0.010 |
Why?
|
| Japan | 1 | 2002 | 1360 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 959 | 0.010 |
Why?
|
| Interleukin-9 | 1 | 1997 | 63 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 1998 | 234 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 444 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.010 |
Why?
|
| Survival Rate | 2 | 2002 | 12788 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2000 | 287 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1663 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2001 | 731 | 0.010 |
Why?
|
| Heterochromatin | 1 | 1999 | 296 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1987 | 2585 | 0.010 |
Why?
|
| Prednisone | 1 | 2002 | 1574 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2007 | 1916 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1880 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 1998 | 336 | 0.010 |
Why?
|
| Cosmids | 1 | 1996 | 107 | 0.010 |
Why?
|
| Aging | 1 | 2015 | 8664 | 0.010 |
Why?
|
| Fibronectins | 1 | 2000 | 726 | 0.010 |
Why?
|
| DEAD-box RNA Helicases | 1 | 1999 | 375 | 0.010 |
Why?
|
| Arabidopsis | 1 | 2000 | 459 | 0.010 |
Why?
|
| China | 1 | 2002 | 2248 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1995 | 26 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 1114 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2001 | 1539 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2242 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2001 | 1284 | 0.010 |
Why?
|
| Selection Bias | 1 | 1997 | 371 | 0.010 |
Why?
|
| Plethysmography | 1 | 1995 | 180 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 1838 | 0.010 |
Why?
|
| Methylene Chloride | 1 | 1994 | 11 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2002 | 1053 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2002 | 2234 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1998 | 903 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1995 | 128 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1999 | 839 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2001 | 2971 | 0.010 |
Why?
|
| Computer Communication Networks | 1 | 1996 | 295 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 62 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2025 | 0.010 |
Why?
|
| Butadienes | 1 | 1994 | 110 | 0.010 |
Why?
|
| Cerebellum | 1 | 2001 | 1488 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1995 | 471 | 0.010 |
Why?
|
| Genes, Retinoblastoma | 1 | 1994 | 136 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 8324 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 53288 | 0.010 |
Why?
|
| Telomere | 1 | 1999 | 910 | 0.010 |
Why?
|
| Leukocytes | 1 | 2001 | 2043 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8301 | 0.010 |
Why?
|
| Syndrome | 1 | 1999 | 3251 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1995 | 1185 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2001 | 1580 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3658 | 0.010 |
Why?
|
| Protein Kinases | 1 | 1998 | 1640 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2002 | 6895 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1993 | 354 | 0.010 |
Why?
|
| Longevity | 1 | 1999 | 1070 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 5751 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 4189 | 0.010 |
Why?
|
| Cell Movement | 1 | 2002 | 5217 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8436 | 0.010 |
Why?
|
| Theophylline | 1 | 1969 | 132 | 0.010 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 1988 | 25 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1988 | 31 | 0.010 |
Why?
|
| Disabled Persons | 1 | 1999 | 1212 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 7023 | 0.010 |
Why?
|
| Plants, Medicinal | 1 | 1969 | 167 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1988 | 278 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 570 | 0.010 |
Why?
|
| Digoxin | 1 | 1969 | 250 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3768 | 0.000 |
Why?
|
| Valine | 1 | 1989 | 413 | 0.000 |
Why?
|
| Peptides | 1 | 1999 | 4409 | 0.000 |
Why?
|
| Hyperglycemia | 1 | 1996 | 1373 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1989 | 449 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1995 | 6365 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12959 | 0.000 |
Why?
|
| Flavonoids | 1 | 1969 | 443 | 0.000 |
Why?
|
| Magnesium | 1 | 1969 | 813 | 0.000 |
Why?
|
| Purines | 1 | 1969 | 594 | 0.000 |
Why?
|
| Health Status | 1 | 1999 | 4034 | 0.000 |
Why?
|
| Neovascularization, Pathologic | 1 | 1995 | 2635 | 0.000 |
Why?
|
| Fruit | 1 | 1991 | 1142 | 0.000 |
Why?
|
| Potassium | 1 | 1969 | 1336 | 0.000 |
Why?
|
| Cricetinae | 1 | 1988 | 2472 | 0.000 |
Why?
|
| Virulence | 1 | 1988 | 1333 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1995 | 2948 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5442 | 0.000 |
Why?
|
| Inflammation | 1 | 2001 | 10638 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 39050 | 0.000 |
Why?
|
| Incidence | 1 | 1999 | 20947 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2001 | 77449 | 0.000 |
Why?
|
| Heart Failure | 1 | 1969 | 10900 | 0.000 |
Why?
|